Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
Ye Li(Nanjing University of Chinese Medicine), Dan S. Kaufman(University of California San Diego)
Cited by 980
Related Papers
Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial
|Nature Medicine|2024|452
Cardiac Repair in a Porcine Model of Acute Myocardial Infarction with Human Induced Pluripotent Stem Cell-Derived Cardiovascular Cells
|Cell stem cell|2014|450
Clinical-Scale Derivation of Natural Killer Cells From Human Pluripotent Stem Cells for Cancer Therapy
|Stem Cells Translational Medicine|2013|413
Human Induced Pluripotent Stem Cell-Derived Macrophages Ameliorate Liver Fibrosis
|Stem Cells|2021|54
Next‐generation chimeric antigen receptors for T‐ and natural killer‐cell therapies against cancer
|Immunological Reviews|2023|31